DOI:
10.1039/D6SC01871H
(Edge Article)
Chem. Sci., 2026, Advance Article
Construction of axial chirality through addressing the meta constraint in the Catellani reaction
Received
5th March 2026
, Accepted 15th May 2026
First published on 19th May 2026
Abstract
Axially chiral biaryls represent an important class of atropisomers that are prevalent in organic ligands, bioactive molecules, and materials. Despite recent advances in the synthesis of atropisomers via the Catellani reaction, the construction of axial chirality at the meta position of aryl iodides remains unexplored due to the low reactivity of aryl iodides with bulky meta substituents, known as the meta constraint. Herein, we report that introducing a directing group at the meta position of aryl iodides enables the formation of the aryl-norbornyl-palladacycle (ANP) intermediate, thereby successfully addressing the meta constraint. Computational studies show that the designed directing group favors a palladium–potassium heterodimer low barrier transition state, enabling palladium to cleave ortho-C–H bonds so as to form the ANP intermediate in an enantioselective manner. A variety of indoloquinolone atropisomers were synthesized with good yields and excellent enantioselectivity using a chiral norbornene (59 examples, up to 80% yield and 99% ee). The practicality of this method is further demonstrated by successful scale-up synthesis and diverse transformations, including the preparation of a chiral[7]helicene and a chiral phosphine ligand. The polycyclic ring systems of the products and their helically chiral derivatives are crucial for potential applications in organic optoelectronic materials.
Introduction
The breakthroughs in palladium/norbornene (NBE) cooperative catalysis (Catellani reaction1–7) have provided a powerful disconnection strategy for target-oriented synthesis, enabling the efficient construction of polysubstituted arenes directly from simple aryl halides.8–22 Despite its potential, this strategy has faced significant challenges primarily because of a fundamental limitation in the Catellani reaction known as the meta constraint.23 Specifically, introducing a sizable substituent at the meta position (R1) of aryl halides can severely reduce the efficiency of ortho functionalization, resulting in NBE-tethered side products A and B (Scheme 1a). First, the ortho metalation of intermediate I could not occur efficiently due to the steric hindrance of the meta substituents. By contrast, intermediate I would progress to NBE-tethered side products A.24 Only aryl halides with small meta substituents (e.g., F or OMe) could generate the aryl-norbornyl-palladacycle (ANP) intermediate, thus giving the desired Catellani products.25–28 Additionally, even though the ANP intermediate could be formed successfully, the steric hindrance near the ANP could impede its interaction with the electrophiles (E). This steric hindrance may instead favor direct reductive elimination, leading to the formation of undesired norbornyl-benzocyclobutene byproduct B by the least sterically demanding pathway possible.29 To address this challenge, Lautens realized the intramolecular electrophilic reaction between electrophiles and ANP using substrates tethered with a meta electrophile.30–32 This “meta constraint” was first summarized and overcome by Dong and co-workers.33 They developed a strategy using a modified NBE and dual X- and L-type ligands to promote the formation of the ANP intermediate (Scheme 1b). Primary alkyl iodides were proven to be suitable electrophiles to finish the ortho alkylation reaction. However, ortho amination and ortho acylation reactions were achieved less effectively. Thus, to enable the Pd/NBE catalysis to become a more general method for synthesizing polysubstituted arenes, the development of a new strategy to overcome the meta constraint, especially when both meta substituents and electrophiles are bulky, is essential.
 |
| | Scheme 1 The meta constraint in the Catellani reaction. | |
On the other hand, the construction of axial chirality has garnered considerable research interest in recent decades, owing to its versatile applications in organic ligands, pharmaceuticals, agrochemicals, and functional materials.34–38 Transition metal-catalyzed enantioselective C–H functionalization enables the introduction of axial chirality in an efficient and atom-economic manner.39,40 The synthesis of chiral molecules via the Catellani reaction was widely studied by Lautens,31 Yu,41–43 Gu,44 Dong,45,46 Zhou,47–55 our group,56–58 and others.59–63 The application of this method to the synthesis of atropisomers is limited, yet highly desirable. In 2018, Gu reported the building of axial chirality at the ipso position of aryl iodides via the Catellani reaction using a chiral phosphine ligand.44 Subsequently, Zhou developed a Pd/chiral NBE-catalyzed construction of axial chirality at the ortho position of aryl iodides.47,49 However, the construction of axial chirality at the meta position of aryl iodides via Pd/NBE cooperative catalysis remains a major challenge due to the meta constraint.
We speculated that aryl iodides tethered with a directing group at the meta position can potentially assist the enantioselective formation of the ANP intermediate, resulting in Catellani products (Scheme 1c). However, the generation of intermediate III is exceedingly challenging because (1) ligand exchange between strongly coordinating phosphine ligands and weakly coordinating oxygen ligands is unlikely and (2) the newly formed 10-membered ring (outlined in color in intermediate III) is highly distorted as a result of the ring strain. Yu and Houk reported that the meta-C–H activation could occur through the lowest accessible transition state that contains a heterodimeric Pd–(OAc)–Ag complex, in which the directing group coordinates to Ag, rather than Pd.64–68 Inspired by these studies, we propose that the directing group at the meta position of aryl iodide substrates may coordinate K, which bridges the Pd by carbonate, placing Pd adjacent to the desired ortho-C–H bond (TS3). We reported herein an atroposelective synthesis of indoloquinolone atropisomers via the Pd/chiral NBE-catalyzed ortho C–H arylation/ipso amination reaction of meta substituted aryl iodides with 3-bromo-indole-2-carboxamides. Our directing group design and experimental efforts were guided by computational studies, and the reaction mechanism involving a heterodimeric Pd–(CO3)–K complex for this novel strategy's high yields and enantioselectivities was also evaluated by computational studies.
Results and discussion
To test our hypothesis, a model reaction using diethyl (1-(3-iodo-4-methylphenyl)naphthalen-2-yl)phosphonate (1p) and 3-bromo-1-methyl-N-propyl-1H-indole-2-carboxamide (2a) as substrates was conducted. After a comprehensive evaluation of various reaction parameters, it was identified that the anticipated product 3p retains a good reaction efficiency and excellent enantioselectivity (71%, 91% ee) under the following optimal reaction conditions: Pd(OAc)2 (10 mol%) as the catalyst, TFP (10 mol%) as the ligand, NBE–CO2Me (50 mol%, >99% ee) as the chiral mediator69 and 2.5 equivalents of K2CO3 as the base in DMSO (0.2 M) at 100 °C (Table 1, entry 1). A set of control experiments was subsequently conducted to understand the role of each component. Not surprisingly, in the absence of the Pd catalyst or NBE–CO2Me, no desired product 3p was observed (entries 2 and 3). PdCl2 was found to give slightly lower yield and enantioselectivity than Pd(OAc)2 (entry 4). TFP is a better ligand than PPh3 in terms of both reaction efficiency and enantioselectivity (entry 5). When a weaker base Na2CO3 was used instead of K2CO3, the yield decreased dramatically (entry 6). Poor yield was obtained when DMF was used as the solvent (entry 7). Changing the NBE–CO2Me to other ester NBE N1 (ref. 45) or amide NBE N2 (ref. 70) led to slightly lower yield and ee of 3p (entries 8 and 9). However, only a trace of product was observed using amide NBE N3 (ref. 70) as a mediator (entry 10). The use of achiral NBE as a mediator and (R)-BINAP as a ligand only generated 3p in 12% yield with 0% ee (entry 11). Reducing the loading of NBE–CO2Me afforded the desired product with a significantly diminished yield (entry 12).
Table 1 Optimization of the reaction conditions

|
| Entry |
Variation of reaction conditionsa |
Yieldb (%) |
eec (%) |
| Reaction conditions unless otherwise noted: 1p (0.10 mmol), 2a (0.15 mmol), Pd(OAc)2 (0.01 mmol), TFP (0.02 mmol), NBE–CO2Me (0.05 mmol), K2CO3 (0.25 mmol), DMSO (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. Yields of isolated products. Determined by chiral HPLC. (R)-2,2′-Bis(diphenylphosphaneyl)-1,1′-binaphthalene (BINAP) instead of TFP. TFP = tri(2-furyl)phosphane. DMF = N,N-dimethylformamide. DMSO = dimethyl sulfoxide. |
| 1 |
None |
71 |
91 |
| 2 |
No Pd(OAc)2 |
0 |
— |
| 3 |
No NBE–CO2Me |
0 |
— |
| 4 |
PdCl2 instead of Pd(OAc)2 |
59 |
89 |
| 5 |
PPh3 instead of TFP |
51 |
90 |
| 6 |
Na2CO3 instead of K2CO3 |
26 |
90 |
| 7 |
DMF instead of DMSO |
26 |
90 |
| 8 |
N1 instead of NBE–CO2Me |
67 |
90 |
| 9 |
N2 instead of NBE–CO2Me |
58 |
88 |
| 10 |
N3 instead of NBE–CO2Me |
Trace |
— |
| 11d |
NBE instead of NBE–CO2Me |
12 |
0 |
| 12 |
25 mol% NBE–CO2Me |
49 |
91 |
With the optimized reaction conditions identified, we then attempted to probe the generality of the reaction by testing a representative set of directing groups (Scheme 2a). It was found that the directing groups had a significant influence on the reaction regarding both reactivity and enantioselectivity. When the aryl iodide (3a) lacks a directing group, no target product is formed. Aryl iodides with benzyl (3b), amine (3c), hydroxyl (3d), benzamido (3e), benzoyl (3f), and carboxylic acid (3g) as directing groups all resulted in no desired products. A substrate with a methoxy directing group could provide the desired product (3h) in good yield, albeit in poor enantioselectivity. To our surprise, when using the cyano group as the directing group, the desired product (3i) was obtained in 65% yield and 90% ee, whereas using the nitro group as the directing group gave the target product (3j) in moderate yield and enantioselectivity. We then investigated carboxylic acid derivatives as directing groups. To our delight, the ester directing group enabled the desired reactivity to provide 3k in 61% yield and 80% ee. We are also pleased to find that a range of amides, including N-phenyl amide, N,N-dimethyl amide, and Weinreb amide, were suitable directing groups, affording the desired indoloquinolone atropisomers (3l–3n) in 35–43% yields and 77–93% ee. However, aryl iodide with an N,N-diphenyl amide group engaged in the reaction ineffectively (3o), likely due to the large steric hindrance of the highly bulky directing group. Next, we examined substrates with phosphonates (1p and 1q) and phosphine oxide (1r) as directing groups, which demonstrated robust reactivity, leading to the desired products (3p–3r) with reasonable yields and excellent enantioselectivities. Finally, meta 2-(diphenylphosphoryl)-6-methylphenyl aryl iodide (1s) was successfully engaged in the reaction, providing the formation of the desired product (3s) with 61% yield and 80% ee.
 |
| | Scheme 2 Evaluation of the directing groups and substrate scope of aryl iodides.a aReaction conditions unless otherwise noted: 1 (0.10 mmol), 2a (0.15 mmol), Pd(OAc)2 (0.01 mmol), TFP (0.02 mmol), NBE–CO2Me (0.05 mmol), K2CO3 (0.25 mmol), DMSO (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. bReaction performed with 1 (0.10 mmol), 2h (0.15 mmol), Pd(OAc)2 (0.01 mmol), TFP (0.02 mmol), NBE–CO2Me (0.05 mmol), KOAc (0.25 mmol), DMSO (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. | |
We next examined the scope of meta 2-(diethoxyphosphoryl)-1-naphthyl aryl iodides 1. As shown in Scheme 2b, a selection of aryl iodides was well tolerated, providing the desired products (4a–4i) in moderate yields (47–73%) and high enantioselectivities (86–92% ee). A variety of substituents at the ortho' position were compatible, such as tert-butyldimethylsilyl (TBS)-protected hydroxymethyl (4a), acetoxymethyl (4b), phenoxymethyl (4c), methoxy (4d), isopropoxy (4e), benzyloxy (4f), fluoro (4g), chloro (4h), and trifluoromethyl (4i). Moreover, aryl iodides bearing an electron-donating group (acetamido) at the meta position were also examined, affording the corresponding product 4j in moderate yield and 86% ee and those bearing electron-withdrawing groups (fluoro and methoxycarbonyl) gave the corresponding products (4k and 4l) in moderate yields and 90% ee. To probe stereochemical interdependence, we endeavored to extend the reaction to more complex molecules. Chiral aryl iodides 1 bearing natural product moieties, including diacetone-D-glucose, L-menthol, and estrone, were well tolerated in this protocol, producing the corresponding derivatives (4m–4o) with satisfactory dr value.
To further evaluate the generality of this transformation, the optimized reaction conditions were applied to a range of N-alkyl 3-bromo-indole-2-carboxamides (Scheme 3). Various alkyl substituents on the amide nitrogen atom (R1) were tolerated, and the corresponding products (5a–5e) were obtained generally in moderate yields (41–62%) and good-to-excellent enantioselectivities (87–94% ee). The reaction retained good reactivity when 3-bromo-1-ethyl-indole-2-carboxamide was used as the substrate to deliver 5f in 51% yield and 90% ee. However, unfortunately, when indole substrates bearing Boc, Ts, and Ns protecting groups were employed, none of the desired product was observed.
 |
| | Scheme 3 Scope of 3-bromo-indole-2-carboxamides. aReaction conditions: 1p (0.10 mmol), 2 (0.15 mmol), Pd(OAc)2 (0.01 mmol), TFP (0.02 mmol), NBE–CO2Me (0.05 mmol), K2CO3 (0.25 mmol), DMSO (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. bReaction conditions: 1p (0.10 mmol), 2 (0.15 mmol), Pd(OAc)2 (0.01 mmol), DPPP (0.01 mmol), NBE–CO2Me (0.05 mmol), K2CO3 (0.25 mmol), DMA (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. cReaction performed with 1k (0.10 mmol), 2h (0.15 mmol), Pd(OAc)2 (0.01 mmol), TFP (0.02 mmol), NBE–CO2Me (0.05 mmol), KOAc (0.25 mmol), DMSO (0.5 mL) under a N2 atmosphere at 100 °C for 48 h. | |
Subsequently, the reaction scope of N-aryl-3-bromo-indole-2-carboxamides was evaluated under slightly modified reaction conditions, including the employment of diphenylphosphopropane (dppp) as the ligand and a solvent change to N,N-dimethylacetamide (DMA). Specifically, a range of N-aryl substrates were subjected to the modified reaction conditions. These reactions resulted in successful generation of the corresponding products (5g–5t), in 63–67% yields and 88–93% ee. Substrates bearing a substituent at the C5 position (R3 = methyl, fluoro, and chloro) were also compatible with this atroposelective protocol, affording corresponding products (5u–5w) with good chiral induction. Besides, the 1-benzyl substrate was also suitable, giving the product (5x) in 47% yield and 91% ee. Particularly noteworthy is that the reaction of the N-phenyl substrate (2h) with aryl iodide bearing an ester group (1k) showed good reactivity and excellent enantioselectivity (5y). Moreover, the absolute configuration of 5y was unambiguously confirmed by X-ray crystallographic analysis.
To elucidate the proposed Pd–K bimetallic catalytic induction model, a systematic mechanistic investigation was conducted using density functional theory (DFT) calculations. The computational results demonstrate that the reaction proceeds through a key C–H activation step involving a heterobimetallic Pd–(CO3)–K transition state, which not only significantly reduces the activation barrier but also underpins the observed high enantioselectivity. As depicted in Fig. 1a, Cat is selected as the zero-potential energy reference for the free energy surface. The catalytic cycle commences with the oxidative addition of aryl iodide 1p to Cat, which proceeds via transition state TS1 with a remarkably low energy barrier of only 2.1 kcal mol−1, yielding arylpalladium(II) intermediate Int1. Subsequent ligand exchange with NBE–CO2Me to form the olefin coordinated Pd(II)–aryl complex Int2 is endergonic by 14.7 kcal mol−1, attributable to the weak coordinating ability of the olefin. The coordinated NBE–CO2Me then undergoes migratory insertion into the C–Pd bond via transition state TS2, with an overall activation free energy of 22.7 kcal mol−1, affording alkylpalladium(II) species Int3. Following this, Int3 undergoes an intramolecular isomerization to yield Int4, a process that is exergonic by 4.0 kcal mol−1. Subsequently, ligand exchange with Int5 leads to the formation of Int6 and Int7. In Int6, the potassium ion is stabilized in a trigonal coordination environment by a carbonate ligand and a phosphine oxide group. The key concerted metalation–deprotonation (CMD) step then proceeds via a six-membered-ring transition state TS3 to generate Int9 This step exhibits an overall activation barrier of 17.3 kcal mol−1 and is exergonic by 14.5 kcal mol−1, indicating its irreversible nature under the reaction conditions. In contrast, the corresponding transition state for the S-configured pathway (TS4) was calculated to be higher in energy by 3.2 kcal mol−1 (purple dashed lines), consistent with the predominant formation of the R-configured product observed experimentally. Following the C–H activation, Int7 undergoes a sequence of transformations including oxidative addition/reductive elimination and β-carbon elimination/N–H bond activation/reductive elimination, ultimately furnishing the final R-configured product 3l (see SI Fig. S3 for details).
 |
| | Fig. 1 (a) DFT calculations for the Pd/chiral NBE-catalyzed ortho C–H arylation/ipso amination reaction. All energy values are reported in kcal mol−1. (b) Optimized geometries and IGMH analysis of transition states TS3 and TS4. The bond lengths are given in angstroms. | |
To elucidate the stereochemical origin in the CMD step, we analyzed the optimized geometries of TS3 and TS4 (Fig. 1b). In TS3, a stabilizing cation–π interaction is clearly observed between the furan ring of the ligand and the potassium ion, which contributes to the stabilization of this transition state. In contrast, such an interaction is absent in TS4. This conclusion is further corroborated by an independent gradient model based on Hirshfeld partition (IGMH) analysis.
To illustrate the synthetic value of this synthetic strategy, we performed two scale up experiments (2.0 mmol), which afforded the desired products 3r and 5y without any loss of the reaction efficiency and enantioselectivity (Scheme 4a). Given the significance of axially chiral skeletons 3r and 5y in organic synthesis, several transformations were performed (Scheme 4b). The reaction of 3r (92% ee) with Lawesson's reagent could generate the phosphine sulfide 6 in 83% yield with 88% ee. Then, 3r was reduced by HSiCl3 to give axially chiral phosphine 7 in 81% yield and 92% ee. In addition, starting from 5y (99% ee), the convenient synthesis of chiral[7]helicene 8 was also readily accomplished via sequential hydrolysis, chlorination of acyl groups, and an intramolecular Friedel–Crafts reaction, with efficiency (85% yield and 82% ee). Hydrolysis of 5y and subsequent Curtius rearrangement of the resulting carboxylic acid delivered the corresponding axially chiral amine 9 in 56% yield with 80% ee. To further explore the synthetic utility of this protocol, palladium-catalyzed asymmetric amination using 7 as a ligand was conducted, furnishing the desired product 12 in 65% yield and 47% ee without optimization of the reaction conditions (Scheme 4c).
 |
| | Scheme 4 Gram-scale reactions, transformations, and synthetic application. Reaction conditions are as follows: a3r (0.10 mmol), Lawesson's reagent (2.0 equiv.), toluene (2.0 mL), N2, 105 °C, 12 h. b3r (0.10 mmol), Et3N (7.0 equiv.), HSiCl3 (5.0 equiv.), toluene (2.0 mL), N2, 105 °C, 12 h. c(1) 5y (0.10 mmol), MeOH/H2O (3/1), KOH (2.5 equiv.), 100 °C, 12 h; (2) (COCl)2 (4.0 equiv.), DMF (2 drops), DCM (3.0 mL), N2, rt, 12 h; (3) AlCl3 (4.0 equiv.), N2, rt, overnight. d(1) 5y (0.10 mmol), MeOH/H2O (3/1), KOH (2.5 equiv.), 100 °C, 12 h, (2) TsN3 (1.2 equiv.), K2CO3 (2.0 equiv.), 80 °C, 12 h. | |
To further demonstrate the potential applications of the desired chiral indoloquinolone atropisomers in materials science, photophysical and chiroptical characterization of selected synthetic derivatives was conducted in dichloromethane (Scheme 5). First, the UV/Vis absorption and fluorescence spectra of 3l, 3p, 3q, 3r, 5l, 5y, and 8 in dichloromethane with a specific concentration (c = 1.00 × 10−5 M) were measured. Broadened fluorescence bands were observed across all compounds, while the chiral[7]helicene 8 demonstrated the most significant bathochromic shift, achieving the longest-wavelength emission maxima in both UV-Vis absorption and fluorescence spectra (Scheme 5a and b, and also see Fig. S8–S15 in the SI for details). Next, the solvatochromism effects of 3q in different solvents (Scheme 5c) were obtained. The emission solvatochromism of phosphine oxide 3q showed significant solvent-dependent behavior, with increasing solvent orientation polarizability. Notably, a dual emission at 397 and 334 nm was detected for 3q in 1,2-dichloroethane. Moreover, the fluorescence quantum yields (ΦF) of 3q were also measured in several solvents, revealing the highest 16.97% in toluene (Scheme 5d). Finally, the fluorescence quantum yields (ΦF) of selected derivatives were quantified under standardized conditions, ranging from 0.66% to 13.15% (Scheme 5e, see Table S16 in the SI for details).
 |
| | Scheme 5 Investigations of photophysical properties. | |
Conclusions
In summary, we have realized a palladium/chiral NBE-catalyzed atroposelective ortho C–H arylation/ipso amination of meta substituted aryl iodides with 3-bromo-indole-2-carboxamides. The catalytic system overcomes the low reactivity of aryl iodides with a bulky meta substituent by introduction of a directing group to achieve the formation of an aryl-norbornyl-palladacycle intermediate, generating a range of indoloquinolone atropisomers in high reactivity and excellent enantioselectivity. The computational results indicated that potassium ions were involved in the transition state, forming the Pd–(CO3)–K bimetallic bridge to provide lower energy barriers. Further derivatizations and photophysical studies highlighted the promising potential for applications in phosphine ligand and organic optoelectronic materials. We anticipate that this method will not only pave the way for discovering other ortho C–H functionalizations of meta substituted aryl iodides but also inspire the development of new strategies for addressing the meta constraint in the Catellani reaction.
Author contributions
G. C. conceived the work and designed the experiments. J. G. performed the laboratory experiments. Y. L., X. W., Z. L., J. Z., and X. W. explored the substrate scope. S. L. performed the DFT calculations. J. G., S. L., and G. C. analysed the data and co-wrote the manuscript.
Conflicts of interest
There are no conflicts to declare.
Data availability
Supplementary information (SI): experimental procedures, mechanistic experiments, characterization data of all the indoloquinolone atropisomers and X-ray data of 5y. See DOI: https://doi.org/10.1039/d6sc01871h.
Acknowledgements
This work was supported by the Natural Science Foundation of Fujian Province (2026J001740), the Natural Science Foundation of Xiamen (3502Z202573048), the National Natural Science Foundation of China (22071068 and 22501069), the Postdoctoral Fellowship Program of CPSF under Grant Number GZC20250669, the Open Cooperation Foundation of the Department of Chemical Science of Henan University (DCSHENU2401), and the Instrumental Analysis Center of Huaqiao University.
Notes and references
- M. Catellani, F. Frignani and A. Rangoni, Angew. Chem., Int. Ed., 1997, 36, 119–122 CrossRef CAS.
- J. Ye and M. Lautens, Nat. Chem., 2015, 7, 863–870 CrossRef CAS PubMed.
- J. Wang and G. Dong, Chem. Rev., 2019, 119, 7478–7528 CrossRef CAS PubMed.
- Z. Chen and F. Zhang, Tetrahedron, 2023, 134, 133307 CrossRef CAS.
- H.-G. Cheng, S. Jia and Q. Zhou, Acc. Chem. Res., 2023, 56, 573–591 CrossRef CAS PubMed.
- D. Dupommier and T. Besset, Chem, 2024, 10, 2651–2665 CAS.
- J. Ge, X. Wu, Y. Liu, Z. Li, J. Zhang, X.-S. Wang and G. Cheng, Chin. J. Chem., 2026, 44, 2202–2224 Search PubMed.
- X. Li, J. Pan, S. Song and N. Jiao, Chem. Sci., 2016, 7, 5384–5389 RSC.
- V. Botla, M. Fontana, A. Voronov, R. Maggi, E. Motti, G. Maestri and N. Della Ca, Angew. Chem., Int. Ed., 2023, 62, e202218928 CrossRef CAS PubMed.
- S. Choi and G. Dong, J. Am. Chem. Soc., 2024, 146, 9512–9518 CrossRef CAS PubMed.
- D. Dupommier, M. Vuagnat, J. Rzayev, S. Roy, P. Jubault and T. Besset, Angew. Chem., Int. Ed., 2024, 63, e202403950 CrossRef CAS PubMed.
- M. Elsaid, R. Ge, C. Liu, D. Maiti and H. Ge, Angew. Chem., Int. Ed., 2023, 62, e202303110 CrossRef CAS PubMed.
- M. Mrozowicz, S. Chatterjee, M. A. Mermigki, D. A. Pantazis and T. Ritter, Angew. Chem., Int. Ed., 2024, 64, e202419472 CrossRef PubMed.
- V. Sukowski, M. van Borselen, S. Mathew, B. de Bruin and M. Á. Fernández-Ibáñez, Angew. Chem., Int. Ed., 2024, 63, e202317741 CrossRef CAS PubMed.
- K.-L. Tao, X. Wang, H. Liu, W.-Q. Chen, Y. Sun, Y.-Q. Zhang, Y.-X. Li, Z.-Y. Wang, Y. Ye, H. Xu, L. Lan and H.-X. Dai, Nat. Synth., 2025, 4, 209–218 CrossRef CAS.
- F.-Y. Wang, Y.-X. Li and L. Jiao, J. Am. Chem. Soc., 2023, 145, 4871–4881 CrossRef CAS PubMed.
- J.-S. Wang, Z. Liu, G. Qian, X. Chen, L. Cao, T. Yu, J. Ye, Y. Ma, S. Chen, Z. Yang, H.-G. Cheng, Y.-F. Yang and Q. Zhou, Angew. Chem., Int. Ed., 2025, 64, e202509300 CrossRef CAS PubMed.
- X.-X. Wang and L. Jiao, J. Am. Chem. Soc., 2024, 146, 25552–25561 CrossRef CAS PubMed.
- Y. Xu, L. Wang, A. Yang, J. Ren, J. Liu and X. Luan, Angew. Chem., Int. Ed., 2025, 64, e202424604 CrossRef CAS PubMed.
- R. Ye, X. Liu and G. Dong, Angew. Chem., Int. Ed., 2025, 64, e202500897 CrossRef CAS PubMed.
- Q. Zhu, J. M. Taylor, X. Liu and G. Dong, J. Am. Chem. Soc., 2025, 147, 43098–43104 CAS.
- Y.-X. Zheng and L. Jiao, Nat. Synth., 2022, 1, 180–187 CrossRef CAS.
- M. Lautens, J.-F. Paquin, S. Piguel and M. Dahlmann, J. Org. Chem., 2001, 66, 8127–8134 CrossRef CAS PubMed.
- G. Maestri, E. Motti, N. Della Ca', M. Malacria, E. Derat and M. Catellani, J. Am. Chem. Soc., 2011, 133, 8574–8585 CrossRef CAS PubMed.
- T. Wilhelm and M. Lautens, Org. Lett., 2005, 7, 4053–4056 CrossRef CAS PubMed.
- G. Maestri, N. Della Ca’ and M. Catellani, Chem. Commun., 2009, 4892–4894 RSC.
- G. Cheng, P. Wang and J.-Q. Yu, Angew. Chem., Int. Ed., 2017, 56, 8183–8186 CrossRef CAS PubMed.
- H. Zhang, P. Chen and G. Liu, Angew. Chem., Int. Ed., 2014, 53, 10174–10178 CrossRef CAS PubMed.
- S. Liu, Z. Jin, Y. C. Teo and Y. Xia, J. Am. Chem. Soc., 2014, 136, 17434–17437 CrossRef CAS PubMed.
- S. Pache and M. Lautens, Org. Lett., 2003, 5, 4827–4830 CrossRef CAS PubMed.
- A. Rudolph, N. Rackelmann and M. Lautens, Angew. Chem., Int. Ed., 2007, 46, 1485–1488 CrossRef CAS PubMed.
- B. Mariampillai, J. Alliot, M. Li and M. Lautens, J. Am. Chem. Soc., 2007, 129, 15372–15379 CrossRef CAS PubMed.
- J. Wang, Y. Zhou, X. Xu, P. Liu and G. Dong, J. Am. Chem. Soc., 2020, 142, 3050–3059 CrossRef CAS PubMed.
- J. Wencel-Delord, A. Panossian, F. R. Leroux and F. Colobert, Chem. Soc. Rev., 2015, 44, 3418–3430 RSC.
- J. A. Carmona, C. Rodríguez-Franco, R. Fernández, V. Hornillos and J. M. Lassaletta, Chem. Soc. Rev., 2021, 50, 2968–2983 RSC.
- Z.-X. Zhang, T.-Y. Zhai and L.-W. Ye, Chem Catal., 2021, 1, 1378–1412 CAS.
- T. A. Schmidt, V. Hutskalova and C. Sparr, Nat. Rev. Chem., 2024, 8, 497–517 CrossRef PubMed.
- S.-H. Xiang, W.-Y. Ding, Y.-B. Wang and B. Tan, Nat. Catal., 2024, 7, 483–498 CrossRef CAS.
- C.-X. Liu, W.-W. Zhang, S.-Y. Yin, Q. Gu and S.-L. You, J. Am. Chem. Soc., 2021, 143, 14025–14040 CrossRef CAS PubMed.
- G. Liao and B.-F. Shi, Acc. Chem. Res., 2025, 58, 1562–1579 CrossRef CAS PubMed.
- H. Shi, A. N. Herron, Y. Shao, Q. Shao and J.-Q. Yu, Nature, 2018, 558, 581–585 CrossRef CAS PubMed.
- J.-J. Li, J.-H. Zhao, H.-C. Shen, K. Wu, X. Kuang, P. Wang and J.-Q. Yu, Chem, 2023, 9, 1452–1463 CAS.
- J.-J. Li, X.-X. Zeng, X. Kuang, H.-C. Shen, P. Wang and J.-Q. Yu, J. Am. Chem. Soc., 2025, 147, 6594–6603 CrossRef CAS PubMed.
- L. Ding, X. Sui and Z. Gu, ACS Catal., 2018, 8, 5630–5635 CrossRef CAS.
- R. Li, F. Liu and G. Dong, Org. Chem. Front., 2018, 5, 3108–3112 RSC.
- A. J. Rago, R. Ye, X. Liu and G. Dong, Chem. Sci., 2024, 15, 1318–1323 RSC.
- Z.-S. Liu, Y. Hua, Q. Gao, Y. Ma, H. Tang, Y. Shang, H.-G. Cheng and Q. Zhou, Nat. Catal., 2020, 3, 727–733 CrossRef CAS.
- Z.-S. Liu, P.-P. Xie, Y. Hua, C. Wu, Y. Ma, J. Chen, H.-G. Cheng, X. Hong and Q. Zhou, Chem, 2021, 7, 1917–1932 CAS.
- Q. Gao, C. Wu, S. Deng, L. Li, Z.-S. Liu, Y. Hua, J. Ye, C. Liu, H.-G. Cheng, H. Cong, Y. Jiao and Q. Zhou, J. Am. Chem. Soc., 2021, 143, 7253–7260 CrossRef CAS PubMed.
- L. Zhou, H.-G. Cheng, L. Li, K. Wu, J. Hou, C. Jiao, S. Deng, Z. Liu, J.-Q. Yu and Q. Zhou, Nat. Chem., 2023, 15, 815–823 CrossRef CAS PubMed.
- H. Peng, D. Wang, J. Ye, Z.-S. Liu, Z. Zhu, X. Fu, C. Liu, H. Cong, H.-G. Cheng and Q. Zhou, J. Am. Chem. Soc., 2025, 147, 3670–3678 CrossRef CAS PubMed.
- L. Li, J. Ye, L. Zhao, L. Zhou, S. Deng, D. Wang, Y. Zhang, H. Cong, Q. Zhou and H.-G. Cheng, J. Am. Chem. Soc., 2025, 147, 39721–39731 CrossRef CAS.
- B. Ding, Q. Xue, H. Wei, J. Chen, Z.-S. Liu, H.-G. Cheng, H. Cong, J. Tang and Q. Zhou, Chem. Sci., 2024, 15, 7975–7981 RSC.
- Y. You, H. Cheng, X. Huang, P. Wang, H. Cong, H.-G. Cheng and Q. Zhou, Chem. Sci., 2026, 17, 8968–8975 Search PubMed.
- C. Wu, Z.-S. Liu, Y. Shang, C. Liu, S. Deng, H.-G. Cheng, H. Cong, Y. Jiao and Q. Zhou, Chin. J. Chem., 2024, 42, 699–704 CrossRef CAS.
- W. Lv, Y. Chen, S. Wen, D. Ba and G. Cheng, J. Am. Chem. Soc., 2020, 142, 14864–14870 CrossRef CAS PubMed.
- Q. Tian, J. Ge, Y. Liu, X. Wu, Z. Li and G. Cheng, Angew. Chem., Int. Ed., 2024, 63, e202409366 CrossRef CAS PubMed.
- Q. Tian, J. Ge, Y. Liu, X. Wu, Z. Li and G. Cheng, Org. Lett., 2025, 27, 121–128 CrossRef CAS PubMed.
- X.-M. Chen, L. Zhu, D.-F. Chen and L.-Z. Gong, Angew. Chem., Int. Ed., 2021, 60, 24844–24848 Search PubMed.
- Y. An, X.-Y. Zhang, Y.-N. Ding, Y. Li, X.-Y. Liu and Y.-M. Liang, Org. Lett., 2022, 24, 7294–7299 CrossRef CAS PubMed.
- P. Gupta, P. C. Tiwari, S. Madhavan and M. Kapur, ACS Catal., 2024, 14, 17460–17468 CrossRef CAS.
- L. Jin, Y. Li, Y. Mao, X.-B. He, Z. Lu, Q. Zhang and B.-F. Shi, Nat. Commun., 2024, 15, 4908 CrossRef CAS PubMed.
- Q. Feng, X. Ma, W. Bao, S.-J. Li, Y. Lan and Q. Song, CCS Chem., 2021, 3, 377–387 CrossRef CAS.
- L. Fang, T. G. Saint-Denis, B. L. H. Taylor, S. Ahlquist, K. Hong, S. Liu, L. Han, K. N. Houk and J.-Q. Yu, J. Am. Chem. Soc., 2017, 139, 10702–10714 CrossRef CAS PubMed.
- Y.-F. Yang, X. Hong, J.-Q. Yu and K. N. Houk, Acc. Chem. Res., 2017, 50, 2853–2860 CrossRef CAS PubMed.
- Z. Fan, K. L. Bay, X. Chen, Z. Zhuang, H. S. Park, K.-S. Yeung, K. N. Houk and J.-Q. Yu, Angew. Chem., Int. Ed., 2020, 59, 4770–4777 CrossRef CAS PubMed.
- M. Wang, S. Liu, H. Liu, Y. Wang, Y. Lan and Q. Liu, Nature, 2024, 631, 556–562 CrossRef CAS PubMed.
- H. Yang, S. Liu, H. Dong, H. Huang, Y. Wang, W. Hao, Y. Lan and Q. Liu, J. Am. Chem. Soc., 2025, 147, 13491–13501 CrossRef CAS PubMed.
- P.-X. Shen, X.-C. Wang, P. Wang, R.-Y. Zhu and J.-Q. Yu, J. Am. Chem. Soc., 2015, 137, 11574–11577 CrossRef CAS PubMed.
- J. Wang, Z. Dong, C. Yang and G. Dong, Nat. Chem., 2019, 11, 1106–1112 Search PubMed.
|
| This journal is © The Royal Society of Chemistry 2026 |
Click here to see how this site uses Cookies. View our privacy policy here.